ESC Professional Premium Access

Randomized double-blind trial to study the benefit of Colchicine in Patients with Acutely Decompensated Heart Failure

Congress Presentation

About the speaker

Professor Domingo Pascual Figal

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)
5 presentations
1 follower

7 more presentations in this session

Low-dose interleukin-2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY) / IVORY - Clinical Outcomes And Follow-up (IVORY FINALE) Study

Speaker: Doctor R. Sriranjan (Cambridge, GB)

Thumbnail

Anakinra versus placebo double blind Randomized controlled trial for the treatment of Acute MyocarditIS

Speaker: Professor M. Kerneis (Paris, FR)

Thumbnail

Colchicine for secondary prevention of stroke and other cardiovascular events: a meta-analysis of randomised trials

Speaker: Mr A. Fiolet (Utrecht, NL)

Thumbnail

Cardiovascular benefit of colchicine in relation to baseline risk

Speaker: Mr N. Mohammadnia (Nijmegen, NL)

Thumbnail

Effect of pre-hospital pulse-dose glucocorticoid on infarct size in st-segment elevation myocardial infarction: a randomized, blinded, placebo-controlled clinical trial

Speaker: Doctor J. Madsen (Copenhagen, DK)

Thumbnail

Access the full session

Smaller trials, trial updates, and other studies on inflammation and immunity in cardiovascular disease

Speakers: Professor D. Pascual Figal, Doctor R. Sriranjan, Professor M. Kerneis, Mr A. Fiolet, Mr N. Mohammadnia...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations